Comorbidities in Neurology: Is adenosine the common link?

Neuropharmacology

Volumn 97, Issue , 2015, Pages 18-34

  Boison, Detlev ^a   Aronica, Eleonora ^b,c  

^a LEGACY RESEARCH   (United States)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

Author keywords

Glial activation; Homeostasis; Human pathology; Inflammation; Mouse model; Neurodegeneration; Purines; Synaptotoxicity

Indexed keywords

ADENOSINE; ADENOSINE KINASE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ASTROCYTOSIS; ATTENTION DEFICIT DISORDER; CELL ACTIVATION; COGNITIVE DEFECT; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; EPIGENETICS; GLIA; HISTOPATHOLOGY; HUMAN; MEMORY DISORDER; MOLECULAR PATHOLOGY; MOTOR CONTROL; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SLEEP DISORDER; SYNAPSE; TEMPORAL LOBE EPILEPSY; ANIMAL; COMPLICATION; METABOLISM; NERVOUS SYSTEM DISEASES; SIGNAL TRANSDUCTION;

ADENOSINE; ANIMALS; COMORBIDITY; HUMANS; NERVOUS SYSTEM DISEASES; NEUROGLIA; SIGNAL TRANSDUCTION;

EID: 84930206148     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2015.04.031     Document Type: Review

References (270)

1. P. Agostinho, R.A. Cunha, and C. Oliveira Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease Curr. Pharm. Des. 16 2010 2766 2778
2. S. Akhondzadeh, A. Safarcherati, and H. Amini Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial Prog. Neuropsychopharmacol. Biol. Psychiatry 29 2005 253 259
3. S. Akhondzadeh, E. Shasavand, H. Jamilian, O. Shabestari, and A. Kamalipour Dipyridamole in the treatment of schizophrenia: adenosine-dopamine receptor interactions J. Clin. Pharm. Ther. 25 2000 131 137
4. E. Aliagas, I. Villar-Menendez, J. Sevigny, M. Roca, M. Romeu, I. Ferrer, M. Martin-Satue, and M. Barrachina Reduced striatal ecto-nucleotidase activity in schizophrenia patients supports the "adenosine hypothesis" Purinergic Signal 9 2013 599 608
5. J.C. Amatniek, W.A. Hauser, C. DelCastillo-Castaneda, D.M. Jacobs, K. Marder, K. Bell, M. Albert, J. Brandt, and Y. Stern Incidence and predictors of seizures in patients with Alzheimer's disease Epilepsia 47 2006 867 872
6. M. Amore, P. Tagariello, C. Laterza, and E.M. Savoia Subtypes of depression in dementia Arch. Gerontol. Geriatr. 44 Suppl. 1 2007 23 33
7. D.J. Anschel, E.L. Ortega, A.C. Kraus, and R.S. Fisher Focally injected adenosine prevents seizures in the rat Exp. Neurol. 190 2004 544 547
8. A. Araque, V. Parpura, R.P. Sanzgiri, and P.G. Haydon Tripartite synapses: glia, the unacknowledged partner Trends Neurosci. 22 1999 208 215
9. J.R. Arch, and E.A. Newsholme Activities and some properties of 5'-nucleotidase, adenosine kinase and adenosine deaminase in tissues from vertebrates and invertebrates in relation to the control of the concentration and the physiological role of adenosine Biochem. J. 174 1978 965 977
10. E. Aronica, and P.B. Crino Epilepsy related to developmental tumors and malformations of cortical development Neurotherapeutics 11 2014 251 268
11. E. Aronica, T. Ravizza, E. Zurolo, and A. Vezzani Astrocyte immune responses and epilepsy Glia 60 2012 1258 1268
12. E. Aronica, U.S. Sandau, A. Iyer, and D. Boison Glial adenosine kinase - a neuropathological marker of the epileptic brain Neurochem. Int. 63 2013 688 695
13. E. Aronica, E. Zurolo, A. Iyer, M. de Groot, J. Anink, C. Carbonell, E.A. van Vliet, J.C. Baayen, D. Boison, and J.A. Gorter Upregulation of adenosine kinase in astrocytes in experimental and human temporal lobe epilepsy Epilepsia 52 2011 1645 1655
14. E. Aso, J. Semakova, L. Joda, V. Semak, L. Halbaut, A. Calpena, C. Escolano, J.C. Perales, and I. Ferrer Triheptanoin supplementation to ketogenic diet curbs cognitive impairment in APP/PS1 mice used as a model of familial Alzheimer's disease Curr. Alzheimer Res. 10 2013 290 297
15. N. Assaife-Lopes, V.C. Sousa, D.B. Pereira, J.A. Ribeiro, M.V. Chao, and A.M. Sebastiao Activation of adenosine A2A receptors induces TrkB translocation and increases BDNF-mediated phospho-TrkB localization in lipid rafts: implications for neuromodulation J. Neurosci. 30 2010 8468 8480
16. N. Atassi, A. Cook, C.M. Pineda, P. Yerramilli-Rao, D. Pulley, and M. Cudkowicz Depression in amyotrophic lateral sclerosis Amyotroph. Lateral Scler. 12 2011 109 112
17. R. Bandopadhyay, J.Y. Liu, S.M. Sisodiya, and M. Thom A comparative study of the dentate gyrus in hippocampal sclerosis in epilepsy and dementia Neuropathol. Appl. Neurobiol. 40 2014 177 190
18. R. Basheer, L. Halldner, L. Alanko, R.W. McCarley, B.B. Fredholm, and T. Porkka-Heiskanen Opposite changes in adenosine A1 and A2A receptor mRNA in the rat following sleep deprivation Neuroreport 12 2001 1577 1580
19. R. Basheer, R.E. Strecker, M.M. Thakkar, and R.W. McCarley Adenosine and sleep-wake regulation Prog. Neurobiol. 73 2004 379 396
20. E. Bastia, Y.H. Xu, A.C. Scibelli, Y.J. Day, J. Linden, J.F. Chen, and M.A. Schwarzschild A crucial role for forebrain adenosine A(2A) receptors in amphetamine sensitization Neuropsychopharmacology 30 2005 891 900
21. J.H. Benington, S.K. Kodali, and H.C. Heller Stimulation of A1 adenosine receptors mimics the electroencephalographic effects of sleep deprivation Brain Res. 692 1995 79 85
22. T.E. Bjorness, C.L. Kelly, T. Gao, V. Poffenberger, and R.W. Greene Control and function of the homeostatic sleep response by adenosine A1 receptors J. Neurosci. 29 2009 1267 1276
23. I. Blumcke, I. Kistner, H. Clusmann, J. Schramm, A.J. Becker, C.E. Elger, C.G. Bien, M. Merschhemke, H.J. Meencke, T. Lehmann, M. Buchfelder, D. Weigel, R. Buslei, H. Stefan, E. Pauli, and M. Hildebrandt Towards a clinico-pathological classification of granule cell dispersion in human mesial temporal lobe epilepsies Acta Neuropathol. 117 2009 535 544
24. I. Blumcke, M. Thom, E. Aronica, D.D. Armstrong, F. Bartolomei, A. Bernasconi, N. Bernasconi, C.G. Bien, F. Cendes, R. Coras, J.H. Cross, T.S. Jacques, P. Kahane, G.W. Mathern, H. Miyata, S.L. Moshe, B. Oz, C. Ozkara, E. Perucca, S. Sisodiya, S. Wiebe, and R. Spreafico International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: a Task Force report from the ILAE Commission on Diagnostic Methods Epilepsia 54 2013 1315 1329
25. T. Blutstein, and P.G. Haydon The importance of astrocyte-derived purines in the modulation of sleep Glia 61 2013 129 139
26. D. Boison Adenosine as a modulator of brain activity Drug News Perspect. 20 2007 607 611
27. D. Boison Adenosine, astrogliosis and seizures: a new perspective of epileptogenesis Neuron Glia Biol. 2 2007 S9-S9
28. D. Boison The adenosine kinase hypothesis of epileptogenesis Prog. Neurobiol. 84 2008 249 262
29. D. Boison Adenosine augmentation therapy for epilepsy J.L. Noebels, M. Avoli, M.A. Rogawski, R.W. Olsen, A.V. Delgado-Escueta, Jasper's Basic Mechanisms of the Epilepsies 2012 Oxford University Press Oxford 1150 1160
30. D. Boison Adenosine dysfunction in epilepsy Glia 60 2012 1234 1243
31. D. Boison Adenosine kinase: exploitation for therapeutic gain Pharmacol. Rev. 65 2013 906 943
32. D. Boison, J.F. Chen, and B.B. Fredholm Adenosine signalling and function in glial cells Cell Death Differ. 17 2010 1071 1082
33. D. Boison, A. Huber, V. Padrun, N. Deglon, P. Aebischer, and H. Mohler Seizure suppression by adenosine-releasing cells is independent of seizure frequency Epilepsia 43 2002 788 796
34. D. Boison, U.S. Sandau, D.N. Ruskin, M. Kawamura Jr., and S.A. Masino Homeostatic control of brain function - new approaches to understand epileptogenesis Front. Cell. Neurosci. 7 2013 109
35. D. Boison, L. Scheurer, J.L. Tseng, P. Aebischer, and H. Mohler Seizure suppression in kindled rats by intraventricular grafting of an adenosine releasing synthetic polymer Exp. Neurol. 160 1999 164 174
36. D. Boison, L. Scheurer, V. Zumsteg, T. Rülicke, P. Litynski, B. Fowler, S. Brandner, and H. Mohler Neonatal hepatic steatosis by disruption of the adenosine kinase gene Proc. Natl. Acad. Sci. U. S. A. 99 2002 6985 6990
37. J. Borycz, M.F. Pereira, A. Melani, R.J. Rodrigues, A. Kofalvi, L. Panlilio, F. Pedata, S.R. Goldberg, R.A. Cunha, and S. Ferre Differential glutamate-dependent and glutamate-independent adenosine A1 receptor-mediated modulation of dopamine release in different striatal compartments J. Neurochem. 101 2007 355 363
38. M.G. Brunstein, E.M. Silveira Jr., L.S. Chaves, H. Machado, O. Schenkel, P. Belmonte-de-Abreu, D.O. Souza, and D.R. Lara Increased serum adenosine deaminase activity in schizophrenic receiving antipsychotic treatment Neurosci. Lett. 414 2007 61 64
39. D.J. Carpenter St. John's wort and S-adenosyl methionine as "natural" alternatives to conventional antidepressants in the era of the suicidality boxed warning: what is the evidence for clinically relevant benefit? Altern. Med. Rev. 16 2011 17 39
40. D.F. Cechetto, V. Hachinski, and S.N. Whitehead Vascular risk factors and Alzheimer's disease Expert Rev. Neurother. 8 2008 743 750
41. J.M. Cerimele, A.P. Stern, and D. Jutras-Aswad Psychosis following excessive ingestion of energy drinks in a patient with schizophrenia Am. J. Psychiatry 167 2010 353
42. J.F. Chen, H.K. Eltzschig, and B.B. Fredholm Adenosine receptors as drug targets-what are the challenges? Nat. Rev. Drug Discov. 12 2013 265 286
43. B. Cheng, X. Yang, L. An, B. Gao, X. Liu, and S. Liu Ketogenic diet protects dopaminergic neurons against 6-OHDA neurotoxicity via up-regulating glutathione in a rat model of Parkinson's disease Brain Res. 1286 2009 25 31
44. F. Ciruela, V. Casado, R.J. Rodrigues, R. Lujan, J. Burgueno, M. Canals, J. Borycz, N. Rebola, S.R. Goldberg, J. Mallol, A. Cortes, E.I. Canela, J.F. Lopez-Gimenez, G. Milligan, C. Lluis, R.A. Cunha, S. Ferre, and R. Franco Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers J. Neurosci. 26 2006 2080 2087
45. N. Coppieters, B.V. Dieriks, C. Lill, R.L. Faull, M.A. Curtis, and M. Dragunow Global changes in DNA methylation and hydroxymethylation in Alzheimer's disease human brain Neurobiol. Aging 35 2014 1334 1344
46. R. Coras, F.A. Siebzehnrubl, E. Pauli, H.B. Huttner, M. Njunting, K. Kobow, C. Villmann, E. Hahnen, W. Neuhuber, D. Weigel, M. Buchfelder, H. Stefan, H. Beck, D.A. Steindler, and I. Blumcke Low proliferation and differentiation capacities of adult hippocampal stem cells correlate with memory dysfunction in humans Brain 133 2010 3359 3372
47. V.H. Cornejo, and C. Hetz The unfolded protein response in Alzheimer's disease Semin. Immunopathol. 35 2013 277 292
48. A.R. Costenla, M.J. Diogenes, P.M. Canas, R.J. Rodrigues, C. Nogueira, J. Maroco, P.M. Agostinho, J.A. Ribeiro, R.A. Cunha, and A. de Mendonca Enhanced role of adenosine A(2A) receptors in the modulation of LTP in the rat hippocampus upon ageing Eur. J. Neurosci. 34 2011 12 21
49. S. Craft The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged Arch. Neurol. 66 2009 300 305
50. R.A. Cunha Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors Neurochem. Int. 38 2001 107 125
51. R.A. Cunha Neuroprotection by adenosine in the brain: from A1 receptor activation to A2A receptor blockade Purinergic Signal. 1 2005 111 134
52. R.A. Cunha Different cellular sources and different roles of adenosine: A(1) receptor-mediated inhibition through astrocytic-driven volume transmission and synapse-restricted A(2A) receptor-mediated facilitation of plasticity Neurochem. Int. 52 2008 65 72
53. R.A. Cunha, S. Ferre, J.M. Vaugeois, and J.F. Chen Potential therapeutic interest of adenosine A(2A) receptors in psychiatric disorders Curr. Pharm. Des. 14 2008 1512 1524
54. P. d'Alcantara, C. Ledent, S. Swillens, and S.N. Schiffmann Inactivation of adenosine A2A receptor impairs long term potentiation in the accumbens nucleus without altering basal synaptic transmission Neuroscience 107 2001 455 464
55. D. De Berardis, S. Marini, N. Serroni, G. Rapini, F. Iasevoli, A. Valchera, M. Signorelli, E. Aguglia, G. Perna, A. Salone, G. Di Iorio, G. Martinotti, and M. Di Giannantonio S-Adenosyl-L-Methionine augmentation in patients with stage II treatment-resistant major depressive disorder: an open label, fixed dose, single-blind study ScientificWorldJournal 2013 2013 204649
56. M. de Groot, A. Iyer, E. Zurolo, J. Anink, J.J. Heimans, D. Boison, C.J. Reijneveld, and E. Aronica Overexpression of ADK in human astrocytic tumors and peritumoral tissue is related to tumor-associated epilepsy Epilepsia 53 2012 58 66
57. P. Desplats, H.J. Lee, E.J. Bae, C. Patrick, E. Rockenstein, L. Crews, B. Spencer, E. Masliah, and S.J. Lee Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein Proc. Natl. Acad. Sci. U. S. A. 106 2009 13010 13015
58. O. Devinsky, A. Vezzani, S. Najjar, N.C. De Lanerolle, and M.A. Rogawski Glia and epilepsy: excitability and inflammation Trends Neurosci. 36 2013 174 184
59. M.J. Diogenes, C.C. Fernandes, A.M. Sebastiao, and J.A. Ribeiro Activation of adenosine A2A receptor facilitates brain-derived neurotrophic factor modulation of synaptic transmission in hippocampal slices J. Neurosci. 24 2004 2905 2913
60. M.J. Diógenes, R. Neves-Tomé, S. Fucile, K. Martinello, M. Scianni, P. Theofilas, J. Lopatář, J.A. Ribeiro, L. Maggi, B.G. Frenguelli, C. Limatola, D. Boison, and A.M. Sebastião Homeostatic control of synaptic activity by endogenous adenosine is mediated by adenosine kinase Cereb. Cortex 24 2014 67 80
61. R.D. Dobkin, M. Menza, L.A. Allen, M.A. Gara, M.H. Mark, J. Tiu, K.L. Bienfait, and J. Friedman Cognitive-behavioral therapy for depression in Parkinson's disease: a randomized, controlled trial Am. J. Psychiatry 168 2011 1066 1074
62. M. Dragunow Adenosine and seizure termination Ann. Neurol. 29 1991 575
63. J.M. Duarte, P.M. Agostinho, R.A. Carvalho, and R.A. Cunha Caffeine consumption prevents diabetes-induced memory impairment and synaptotoxicity in the hippocampus of NONcZNO10/LTJ mice PLoS One 7 2012 e21899
64. T.V. Dunwiddie Endogenously released adenosine regulates excitability in the in vitro hippocampus Epilepsia 21 1980 541 548
65. M.J. During, and D.D. Spencer Adenosine: a potential mediator of seizure arrest and postictal refractoriness Ann. Neurol. 32 1992 618 624
66. G.P. Dutra, G.L. Ottoni, D.R. Lara, and M.R. Bogo Lower frequency of the low activity adenosine deaminase allelic variant (ADA1∗2) in schizophrenic patients Rev. Bras. Psiquiatr. 32 2010 275 278
67. C. Duyckaerts Disentangling Alzheimer's disease Lancet Neurol. 10 2011 774 775
68. M. Dworak, P. Diel, S. Voss, W. Hollmann, and H.K. Struder Intense exercise increases adenosine concentrations in rat brain: implications for a homeostatic sleep drive Neuroscience 150 2007 789 795
69. L.A. Etherington, and B.G. Frenguelli Endogenous adenosine modulates epileptiform activity in rat hippocampus in a receptor subtype-dependent manner Eur. J. Neurosci. 19 2004 2539 2550
70. C. Farina, F. Aloisi, and E. Meinl Astrocytes are active players in cerebral innate immunity Trends Immunol. 28 2007 138 145
71. D.E. Fedele, N. Gouder, M. Güttinger, L. Gabernet, L. Scheurer, T. Rulicke, F. Crestani, and D. Boison Astrogliosis in epilepsy leads to overexpression of adenosine kinase resulting in seizure aggravation Brain 128 2005 2383 2395
72. D.E. Fedele, P. Koch, O. Brüstle, L. Scheurer, E.M. Simpson, H. Mohler, and D. Boison Engineering embryonic stem cell derived glia for adenosine delivery Neurosci. Lett. 370 2004 160 165
73. 1 receptors are crucial in keeping an epileptic focus localized Exp. Neurol. 200 2006 184 190
74. P. Ferentinos, T. Paparrigopoulos, M. Rentzos, V. Zouvelou, T. Alexakis, and I. Evdokimidis Prevalence of major depression in ALS: comparison of a semi-structured interview and four self-report measures Amyotroph. Lateral Scler. 12 2011 297 302
75. G. Fernandez, P. Mandolesi, N.P. Rotstein, O. Colombo, O. Agamennoni, and L.E. Politi Eye movement alterations during reading in patients with early Alzheimer disease Investig. Ophthalmol. Vis. Sci. 54 2013 8345 8352
76. S. Ferre Adenosine-dopamine interactions in the ventral striatum. Implications for the treatment of schizophrenia Psychopharmacology (Berl.) 133 1997 107 120
77. S. Ferre, W.T. O'Connor, P. Snaprud, U. Ungerstedt, and K. Fuxe Antagonistic interaction between adenosine A2A receptors and dopamine D2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia Neuroscience 63 1994 765 773
78. M. Flajolet, Z. Wang, M. Futter, W. Shen, N. Nuangchamnong, J. Bendor, I. Wallach, A.C. Nairn, D.J. Surmeier, and P. Greengard FGF acts as a co-transmitter through adenosine A(2A) receptor to regulate synaptic plasticity Nat. Neurosci. 11 2008 1402 1409
79. L.S. Forno, L.E. DeLanney, I. Irwin, D. Di Monte, and J.W. Langston Astrocytes and Parkinson's disease Prog. Brain Res. 94 1992 429 436
80. R. Franco, C. Lluis, E.I. Canela, J. Mallol, L. Agnati, V. Casado, F. Ciruela, S. Ferre, and K. Fuxe Receptor-receptor interactions involving adenosine A1 or dopamine D1 receptors and accessory proteins J. Neural Transm. 114 2007 93 104
81. S. Fredduzzi, R. Moratalla, A. Monopoli, B. Cuellar, K. Xu, E. Ongini, F. Impagnatiello, M.A. Schwarzschild, and J.F. Chen Persistent behavioral sensitization to chronic L-DOPA requires A2A adenosine receptors J. Neurosci. 22 2002 1054 1062
82. B.B. Fredholm Adenosine receptors in the central nervous system NIPS 10 1995 122 128
83. B.B. Fredholm Adenosine receptors as drug targets Exp. Cell Res. 316 2010 1284 1288
84. B.B. Fredholm, J.F. Chen, R.A. Cunha, P. Svenningsson, and J.M. Vaugeois Adenosine and brain function Int. Rev. Neurobiol. 63 2005 191 270
85. B.B. Fredholm, J.F. Chen, S.A. Masino, and J.M. Vaugeois Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs Annu. Rev. Pharmacol. Toxicol. 45 2005 385 412
86. B.B. Fredholm, and T.V. Dunwiddie How does adenosine inhibit transmitter release? Trends Pharmacol. Sci. 9 1988 130 134
87. B.B. Fredholm, T.V. Dunwiddie, B. Bergman, and K. Lindstrom Levels of adenosine and adenine nucleotides in slices of rat hippocampus Brain Res. 295 1984 127 136
88. B.B. Fredholm, and P. Svenningsson Adenosine-dopamine interactions: development of a concept and some comments on therapeutic possibilities Neurology 61 2003 S5 S9
89. J.M. Freeman Seizures, EEG events, and the ketogenic diet Epilepsia 50 2009 329 330
90. S. Fuller, G. Munch, and M. Steele Activated astrocytes: a therapeutic target in Alzheimer's disease? Expert Rev. Neurother. 9 2009 1585 1594
91. K. Fuxe, L.F. Agnati, K. Jacobsen, J. Hillion, M. Canals, M. Torvinen, B. Tinner-Staines, W. Staines, D. Rosin, A. Terasmaa, P. Popoli, G. Leo, V. Vergoni, C. Lluis, F. Ciruela, R. Franco, and S. Ferre Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson's disease Neurology 61 2003 S19 S23
92. K. Fuxe, S. Ferre, S. Genedani, R. Franco, and L.F. Agnati Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function Physiol. Behav. 92 2007 210 217
93. K. Fuxe, D. Marcellino, S. Genedani, and L. Agnati Adenosine A(2A) receptors, dopamine D(2) receptors and their interactions in Parkinson's disease Mov. Disord. 22 2007 1990 2017
94. K. Fuxe, D. Marcellino, G. Leo, and L.F. Agnati Molecular integration via allosteric interactions in receptor heteromers. A working hypothesis Curr. Opin. Pharmacol. 10 2010 14 22
95. A. Gaitatzis, K. Carroll, A. Majeed, and J.W. Sander The epidemiology of the comorbidity of epilepsy in the general population Epilepsia 45 2004 1613 1622
96. A. Gaitatzis, S.M. Sisodiya, and J.W. Sander The somatic comorbidity of epilepsy: a weighty but often unrecognized burden Epilepsia 53 2012 1282 1293
97. Y.E. Geda, L.S. Schneider, L.N. Gitlin, D.S. Miller, G.S. Smith, J. Bell, J. Evans, M. Lee, A. Porsteinsson, K.L. Lanctot, P.B. Rosenberg, D.L. Sultzer, P.T. Francis, H. Brodaty, P.P. Padala, C.U. Onyike, L.A. Ortiz, S. Ancoli-Israel, D.L. Bliwise, J.L. Martin, M.V. Vitiello, K. Yaffe, P.C. Zee, N. Herrmann, R.A. Sweet, C. Ballard, N.A. Khin, C. Alfaro, P.S. Murray, S. Schultz, C.G. Lyketsos Neuropsychiatric Syndromes Professional Interest Area of, I Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future Alzheimers Dement. 9 2013 602 608
98. M. Glass, R.L. Faull, J.Y. Bullock, K. Jansen, E.W. Mee, E.B. Walker, B.J. Synek, and M. Dragunow Loss of A1 adenosine receptors in human temporal lobe epilepsy Brain Res. 710 1996 56 68
99. N. Goldman, M. Chen, T. Fujita, Q. Xu, W. Peng, W. Liu, T.K. Jensen, Y. Pei, F. Wang, X. Han, J.F. Chen, J. Schnermann, T. Takano, L. Bekar, K. Tieu, and M. Nedergaard Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture Nat. Neurosci. 13 2010 883 888
100. C.V. Gomes, M.P. Kaster, A.R. Tome, P.M. Agostinho, and R.A. Cunha Adenosine receptors and brain diseases: neuroprotection and neurodegeneration Biochim. Biophys. Acta 1808 2011 1380 1399
101. 1 receptor activation in a mouse model of pharmacoresistant epilepsy Epilepsia 44 2003 877 885
102. N. Gouder, L. Scheurer, J.-M. Fritschy, and D. Boison Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis J. Neurosci. 24 2004 692 701
103. M. Güttinger, D.E. Fedele, P. Koch, V. Padrun, W. Pralong, O. Brüstle, and D. Boison Suppression of kindled seizures by paracrine adenosine release from stem cell derived brain implants Epilepsia 46 2005 1 8
104. 1 receptor desensitization after focal long-term delivery of adenosine by encapsulated myoblasts Exp. Neurol. 193 2005 53 64
105. M.M. Halassa, T. Fellin, and P.G. Haydon The tripartite synapse: roles for gliotransmission in health and disease Trends Mol. Med. 13 2007 54 63
106. M.M. Halassa, C. Florian, T. Fellin, J.R. Munoz, S.Y. Lee, T. Abel, P.G. Haydon, and M.G. Frank Astrocytic modulation of sleep homeostasis and cognitive consequences of sleep loss Neuron 61 2009 213 219
107. M.M. Halassa, and P.G. Haydon Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior Annu. Rev. Physiol. 72 2010 335 355
108. E.D. Hall, J.A. Oostveen, and M.E. Gurney Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS Glia 23 1998 249 256
109. M. Hallbeck, S. Nath, and J. Marcusson Neuron-to-neuron transmission of neurodegenerative pathology Neuroscientist 19 2013 560 566
110. G.M. Halliday, and C.H. Stevens Glia: initiators and progressors of pathology in Parkinson's disease Mov. Disord. 26 2011 6 17
111. D.W. Hedges, F.L. Woon, and S.P. Hoopes Caffeine-induced psychosis CNS Spectr. 14 2009 127 129
112. U. Hemmeter, R. Bischof, M. Hatzinger, E. Seifritz, and E. Holsboer-Trachsler Microsleep during partial sleep deprivation in depression Biol. Psychiatry 43 1998 829 839
113. U.M. Hemmeter, J. Hemmeter-Spernal, and J.C. Krieg Sleep deprivation in depression Expert Rev. Neurother. 10 2010 1101 1115
114. D.J. Hines, and P.G. Haydon Astrocytic adenosine: from synapses to psychiatric disorders Philos. Trans. R. Soc. Lond. B Biol. Sci. 369 2014 20130594
115. D.J. Hines, L.I. Schmitt, R.M. Hines, S.J. Moss, and P.G. Haydon Antidepressant effects of sleep deprivation require astrocyte-dependent adenosine mediated signaling Transl. Psychiatry 3 2013 e212
116. T. Hirota, and T. Kishi Adenosine hypothesis in schizophrenia and bipolar disorder: a systematic review and meta-analysis of randomized controlled trial of adjuvant purinergic modulators Schizophr. Res. 149 2013 88 95
117. Z.L. Huang, W.M. Qu, N. Eguchi, J.F. Chen, M.A. Schwarzschild, B.B. Fredholm, Y. Urade, and O. Hayaishi Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine Nat. Neurosci. 8 2005 858 859
118. A. Huber, V. Padrun, N. Deglon, P. Aebischer, H. Mohler, and D. Boison Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy Proc. Natl. Acad. Sci. U. S. A. 98 2001 7611 7616
119. B.T. Hyman, C.H. Phelps, T.G. Beach, E.H. Bigio, N.J. Cairns, M.C. Carrillo, D.W. Dickson, C. Duyckaerts, M.P. Frosch, E. Masliah, S.S. Mirra, P.T. Nelson, J.A. Schneider, D.R. Thal, B. Thies, J.Q. Trojanowski, H.V. Vinters, and T.J. Montine National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease Alzheimers Dement. 8 2012 1 13
120. A. Iyer, A. Prabowo, J. Anink, W.G. Spliet, P.C. van Rijen, and E. Aronica Cell injury and premature neurodegeneration in focal malformations of cortical development Brain Pathol. 24 2014 1 17
121. K.A. Jellinger Neuropathology in Parkinson's disease with mild cognitive impairment Acta Neuropathol. 120 2010 829 830 author reply 831
122. C.J. Jensen, A. Massie, and J. De Keyser Immune players in the CNS: the astrocyte J. Neuroimmune Pharmacol. 8 2013 824 839
123. F.E. Jensen Epilepsy as a spectrum disorder: implications from novel clinical and basic neuroscience Epilepsia 52 Suppl. 1 2011 1 6
124. A. Jeronimo-Santos, V.L. Batalha, C.E. Muller, Y. Baqi, A.M. Sebastiao, L.V. Lopes, and M.J. Diogenes Impact of in vivo chronic blockade of adenosine A2A receptors on the BDNF-mediated facilitation of LTP Neuropharmacology 83 2014 99 106
125. L. Kandratavicius, C. Lopes-Aguiar, L.S. Bueno-Junior, R.N. Romcy-Pereira, J.E. Hallak, and J.P. Leite Psychiatric comorbidities in temporal lobe epilepsy: possible relationships between psychotic disorders and involvement of limbic circuits Rev. Bras. Psiquiatr. 34 2012 454 466
126. G.E. Kisby, and P.S. Spencer Is neurodegenerative disease a long-latency response to early-life genotoxin exposure? Int. J. Environ. Res. Public Health 8 2011 3889 3921
127. K. Kobow, S. Auvin, F. Jensen, W. Loscher, I. Mody, H. Potschka, D. Prince, A. Sierra, M. Simonato, A. Pitkanen, A. Nehlig, and J.M. Rho Finding a better drug for epilepsy: antiepileptogenesis targets Epilepsia 53 2012 1868 1876
128. K. Kobow, and I. Blumcke The methylation hypothesis: do epigenetic chromatin modifications play a role in epileptogenesis? Epilepsia 52 Suppl. 4 2011 15 19
129. K. Kobow, I. Jeske, M. Hildebrandt, J. Hauke, E. Hahnen, R. Buslei, M. Buchfelder, D. Weigel, H. Stefan, B. Kasper, E. Pauli, and I. Blumcke Increased reelin promoter methylation is associated with granule cell dispersion in human temporal lobe epilepsy J. Neuropathol. Exp. Neurol. 68 2009 356 364
130. K. Kobow, A. Kaspi, K.N. Harikrishnan, K. Kiese, M. Ziemann, I. Khurana, I. Fritzsche, J. Hauke, E. Hahnen, R. Coras, A. Muhlebner, A. El-Osta, and I. Blumcke Deep sequencing reveals increased DNA methylation in chronic rat epilepsy Acta Neuropathol. 126 2013 741 756
131. S. Korner, K. Kollewe, J. Ilsemann, A. Muller-Heine, R. Dengler, K. Krampfl, and S. Petri Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis Eur. J. Neurol. 20 2013 647 654
132. E.H. Kossoff, and J.M. Rho Ketogenic diets: evidence for short- and long-term efficacy Neurotherapeutics 6 2009 406 414
133. G.G. Kovacs, and E. Gelpi Clinical neuropathology practice news 3-2012: the "ABC" in AD-revised and updated guideline for the neuropathologic assessment of Alzheimer's disease Clin. Neuropathol. 31 2012 116 118
134. E.A. Kowaluk, and M.F. Jarvis Therapeutic potential of adenosine kinase inhibitors Expert Opin. Investig. Drugs 9 2000 551 564
135. F. L'Episcopo, C. Tirolo, N. Testa, S. Caniglia, M.C. Morale, and B. Marchetti Glia as a turning point in the therapeutic strategy of Parkinson's disease CNS Neurol. Disord. Drug Targets 9 2010 349 372
136. W.C. LaFrance Jr., A.M. Kanner, and B. Hermann Psychiatric comorbidities in epilepsy Int. Rev. Neurobiol. 83 2008 347 383
137. A.J. Larner Epileptic seizures in AD patients Neuromolecular Med. 12 2010 71 77
138. A.J. Larner Presenilin-1 mutation Alzheimer's disease: a genetic epilepsy syndrome? Epilepsy Behav. 21 2011 20 22
139. J. Lasiene, and K. Yamanaka Glial cells in amyotrophic lateral sclerosis Neurol. Res. Int. 2011 2011 718987
140. 2A receptors in the shell of the nucleus accumbens J. Neurosci. 31 2011 10067 10075
141. F.S. Lee, and M.V. Chao Activation of Trk neurotrophin receptors in the absence of neurotrophins Proc. Natl. Acad. Sci. U. S. A. 98 2001 3555 3560
142. A.C. Lepore, C. Dejea, J. Carmen, B. Rauck, D.A. Kerr, M.V. Sofroniew, and N.J. Maragakis Selective ablation of proliferating astrocytes does not affect disease outcome in either acute or chronic models of motor neuron degeneration Exp. Neurol. 211 2008 423 432
143. J.B. Levine, J. Kong, M. Nadler, and Z. Xu Astrocytes interact intimately with degenerating motor neurons in mouse amyotrophic lateral sclerosis (ALS) Glia 28 1999 215 224
144. T. Li, J.Q. Lan, B.B. Fredholm, R.P. Simon, and D. Boison Adenosine dysfunction in astrogliosis: cause for seizure generation? Neuron Glia Biol. 3 2007 353 366
145. T. Li, N. Lytle, J.-Q. Lan, U.S. Sandau, and D. Boison Local disruption of glial adenosine homeostasis in mice associates with focal electrographic seizures: a first step in epileptogenesis? Glia 60 2012 83 95
146. T. Li, G. Ren, D.L. Kaplan, and D. Boison Human mesenchymal stem cell grafts engineered to release adenosine reduce chronic seizures in a mouse model of CA3-selective epileptogenesis Epilepsy Res. 84 2009 238 241
147. T. Li, G. Ren, T. Lusardi, A. Wilz, J.Q. Lan, T. Iwasato, S. Itohara, R.P. Simon, and D. Boison Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice J. Clin. Investig. 118 2008 571 582 PMCID: PMC2157568
148. T. Li, J.A. Steinbeck, T. Lusardi, P. Koch, J.Q. Lan, A. Wilz, M. Segschneider, R.P. Simon, O. Brustle, and D. Boison Suppression of kindling epileptogenesis by adenosine releasing stem cell-derived brain implants Brain 130 2007 1276 1288
149. D. Lovatt, Q. Xu, W. Liu, T. Takano, N.A. Smith, J. Schnermann, K. Tieu, and M. Nedergaard Neuronal adenosine release, and not astrocytic ATP release, mediates feedback inhibition of excitatory activity Proc. Natl. Acad. Sci. U. S. A. 109 2012 6265 6270
150. F.D. Lubin Epileptogenesis: can the science of epigenetics give us answers? Epilepsy Curr. 12 2012 105 110
151. M. Lucas, F. Mirzaei, A. Pan, O.I. Okereke, W.C. Willett, E.J. O'Reilly, K. Koenen, and A. Ascherio Coffee, caffeine, and risk of depression among women Arch. Intern. Med. 171 2011 1571 1578
152. K.M. Lucin, and T. Wyss-Coray Immune activation in brain aging and neurodegeneration: too much or too little? Neuron 64 2009 110 122
153. A. Lutas, and G. Yellen The ketogenic diet: metabolic influences on brain excitability and epilepsy Trends Neurosci. 36 2013 32 40
154. M. Mackiewicz, E.V. Nikonova, J.E. Zimmerman, R.J. Galante, L. Zhang, J.R. Cater, J.D. Geiger, and A.I. Pack Enzymes of adenosine metabolism in the brain: diurnal rhythm and the effect of sleep deprivation J. Neurochem. 85 2003 348 357
155. L. Marsh Depression and Parkinson's disease: current knowledge Curr. Neurol. Neurosci. Rep. 13 2013 409
156. L.J. Martin, and M. Wong Aberrant regulation of DNA methylation in amyotrophic lateral sclerosis: a new target of disease mechanisms Neurotherapeutics 10 2013 722 733
157. A. Martire, M.T. Tebano, V. Chiodi, S.G. Ferreira, R.A. Cunha, A. Kofalvi, and P. Popoli Pre-synaptic adenosine A2A receptors control cannabinoid CB1 receptor-mediated inhibition of striatal glutamatergic neurotransmission J. Neurochem. 116 2011 273 280
158. A. Martorana, M. Bulati, S. Buffa, M. Pellicano, C. Caruso, G. Candore, and G. Colonna-Romano Immunosenescence, inflammation and Alzheimer's disease Longev. Heal. 1 2012 8
159. F. Martorana, L. Brambilla, C.F. Valori, C. Bergamaschi, C. Roncoroni, E. Aronica, A. Volterra, P. Bezzi, and D. Rossi The BH4 domain of Bcl-X(L) rescues astrocyte degeneration in amyotrophic lateral sclerosis by modulating intracellular calcium signals Hum. Mol. Genet. 21 2012 826 840
160. S.A. Masino, T. Li, P. Theofilas, U.S. Sandau, D.N. Ruskin, B.B. Fredholm, J.D. Geiger, E. Aronica, and D. Boison A ketogenic diet suppresses seizures in mice through adenosine A1 receptors J. Clin. Investig. 121 2011 2679 2683
161. S.A. Masino, and J.M. Rho Mechanisms of ketogenic diet action J.L. Noebels, M. Avoli, M.A. Rogawski, R.W. Olsen, A.V. Delgado-Escueta, Jasper's Basic Mechanisms of the Epilepsies, Bethesda (MD) 2012
162. E. Masliah, W. Dumaop, D. Galasko, and P. Desplats Distinctive patterns of DNA methylation associated with Parkinson disease: identification of concordant epigenetic changes in brain and peripheral blood leukocytes Epigenetics 8 2013 1030 1038
163. M. Matos, E. Augusto, N.J. Machado, A. dos Santos-Rodrigues, R.A. Cunha, and P. Agostinho Astrocytic adenosine A2A receptors control the amyloid-beta peptide-induced decrease of glutamate uptake J. Alzheimers Dis. 31 2012 555 567
164. M. Matos, E. Augusto, A.D. Santos-Rodrigues, M.A. Schwarzschild, J.F. Chen, R.A. Cunha, and P. Agostinho Adenosine A2A receptors modulate glutamate uptake in cultured astrocytes and gliosomes Glia 60 2012 702 716
165. M. Matos, H.-Y. Shen, E. Augusto, Y. Wang, C.J. Wei, Y.T. Wang, P. Agostinho, D. Boison, R.A. Cunha, and J.-F. Chen Deletion of adenosine A2A receptors from astrocytes disrupts glutamate homeostasis leading to psychomotor and cognitive impairment: relevance to schizophrenia Biol. Psychiatry 2015 10.1016/j.piopsych.2015.02.026 [Epub ahead of print]
166. S. McGaraughty, M. Cowart, M.F. Jarvis, and R.F. Berman Anticonvulsant and antinociceptive actions of novel adenosine kinase inhibitors Curr. Top. Med. Chem. 5 2005 43 58
167. P.L. McGeer, and E.G. McGeer Inflammatory processes in amyotrophic lateral sclerosis Muscle Nerve 26 2002 459 470
168. P.L. McGeer, and E.G. McGeer Glial reactions in Parkinson's disease Mov. Disord. 23 2008 474 483
169. P. Meghji, and A.C. Newby Sites of adenosine formation, action and inactivation in the brain Neurochem. Int. 16 1990 227 232
170. M. Mendez, and G. Lim Seizures in elderly patients with dementia: epidemiology and management Drugs Aging 20 2003 791 803
171. M. Menza, N. Forman, J. Sage, and R. Cody Psychiatric symptoms in Parkinson's disease: a comparison between patients with and without "on-off" symptoms Biol. Psychiatry 33 1993 682 684
172. M.J. Millan An epigenetic framework for neurodevelopmental disorders: from pathogenesis to potential therapy Neuropharmacology 68 2013 2 82
173. A.A. Miller, and S.J. Spencer Obesity and neuroinflammation: a pathway to cognitive impairment Brain Behav. Immun. 42 2014 10 21
174. R.E. Mrak, and W.S. Griffin Potential inflammatory biomarkers in Alzheimer's disease J. Alzheimers Dis. 8 2005 369 375
175. R.G. Nagele, J. Wegiel, V. Venkataraman, H. Imaki, K.C. Wang, and J. Wegiel Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease Neurobiol. Aging 25 2004 663 674
176. R. Nahas, and O. Sheikh Complementary and alternative medicine for the treatment of major depressive disorder Can. Fam. Physician 57 2011 659 663
177. H.W. Nam, S.R. McIver, D.J. Hinton, M.M. Thakkar, Y. Sari, F.E. Parkinson, P.G. Haydon, and D.S. Choi Adenosine and glutamate signaling in neuron-glial interactions: implications in alcoholism and sleep disorders Alcohol. Clin. Exp. Res. 36 2012 1117 1125
178. C. Neusch, M. Bahr, and C. Schneider-Gold Glia cells in amyotrophic lateral sclerosis: new clues to understanding an old disease? Muscle Nerve 35 2007 712 724
179. A.C. Newby Adenosine and the concept of 'retaliatory metabolites' Trends Biochem. Sci. 9 1984 42 44
180. R. Niranjan The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson's disease: focus on astrocytes Mol. Neurobiol. 49 2014 28 38
181. J. Noebels A perfect storm: converging paths of epilepsy and Alzheimer's dementia intersect in the hippocampal formation Epilepsia 52 Suppl. 1 2011 39 46
182. A.G. Orr, E.C. Hsiao, M.M. Wang, K. Ho, D.H. Kim, X. Wang, W. Guo, J. Kang, G.Q. Yu, A. Adame, N. Devidze, D.B. Dubal, E. Masliah, B.R. Conklin, and L. Mucke Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory Nat. Neurosci. 18 2015 423 434
183. J.J. Palop, and L. Mucke Epilepsy and cognitive impairments in Alzheimer disease Arch. Neurol. 66 2009 435 440
184. W. Paulus, and K. Jellinger The neuropathologic basis of different clinical subgroups of Parkinson's disease J. Neuropathol. Exp. Neurol. 50 1991 743 755
185. G. Perez-Madrinan, S.E. Cook, J.A. Saxton, S. Miyahara, O.L. Lopez, D.I. Kaufer, H.J. Aizenstein, S.T. DeKosky, and R.A. Sweet Alzheimer disease with psychosis: excess cognitive impairment is restricted to the misidentification subtype Am. J. Geriatr. Psychiatry 12 2004 449 456
186. V.H. Perry Innate inflammation in Parkinson's disease Cold Spring Harb. Perspect. Med. 2 2012 a009373
187. R. Pihlaja, J. Koistinaho, T. Malm, H. Sikkila, S. Vainio, and M. Koistinaho Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease Glia 56 2008 154 163
188. M. Polymenidou, and D.W. Cleveland Prion-like spread of protein aggregates in neurodegeneration J. Exp. Med. 209 2012 889 893
189. T. Porkka-Heiskanen, R.E. Strecker, M. Thakkar, A.A. Bjørkum, R.W. Greene, and R.W. McCarley Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness Science 276 1997 1265 1268
190. A.S. Prabowo, A.M. Iyer, T.J. Veersema, J.J. Anink, A.Y. Schouten-van Meeteren, W.G. Spliet, P.C. van Rijen, C.H. Ferrier, M. Thom, and E. Aronica Expression of neurodegenerative disease-related proteins and caspase-3 in glioneuronal tumours Neuropathol. Appl. Neurobiol. 41 2015 e1 e15
191. C. Quiroz, R. Lujan, M. Uchigashima, A.P. Simoes, T.N. Lerner, J. Borycz, A. Kachroo, P.M. Canas, M. Orru, M.A. Schwarzschild, D.L. Rosin, A.C. Kreitzer, R.A. Cunha, M. Watanabe, and S. Ferre Key modulatory role of presynaptic adenosine A2A receptors in cortical neurotransmission to the striatal direct pathway ScientificWorldJournal 9 2009 1321 1344
192. I.A. Qureshi, and M.F. Mehler Epigenetic mechanisms underlying human epileptic disorders and the process of epileptogenesis Neurobiol. Dis. 39 2010 53 60
193. S.C. Rao, G. Dove, G.D. Cascino, and R.C. Petersen Recurrent seizures in patients with dementia: frequency, seizure types, and treatment outcome Epilepsy Behav. 14 2009 118 120
194. P.M. Rappold, and K. Tieu Astrocytes and therapeutics for Parkinson's disease Neurotherapeutics 7 2010 413 423
195. T. Ravizza, C. Kostoula, and A. Vezzani Immunity activation in brain cells in epilepsy: mechanistic insights and pathological consequences Neuropediatrics 44 2013 330 335
196. 1 receptor density and of adenosine neuromodulation in the hippocampus of kindled rats Eur. J. Neurosci. 18 2003 820 828
197. N. Rebola, R. Lujan, R.A. Cunha, and C. Mulle Adenosine A2A receptors are essential for long-term potentiation of NMDA-EPSCs at hippocampal mossy fiber synapses Neuron 57 2008 121 134
198. J.S. Reijnders, U. Ehrt, W.E. Weber, D. Aarsland, and A.F. Leentjens A systematic review of prevalence studies of depression in Parkinson's disease Mov. Disord. 23 2008 183 189 quiz 313
199. G. Ren, T. Li, J.Q. Lan, A. Wilz, R.P. Simon, and D. Boison Lentiviral RNAi-induced downregulation of adenosine kinase in human mesenchymal stem cell grafts: a novel perspective for seizure control Exp. Neurol. 208 2007 26 37
200. A. Restrepo, C.A. Smith, S. Agnihotri, M. Shekarforoush, P.N. Kongkham, H.J. Seol, P. Northcott, and J.T. Rutka Epigenetic regulation of glial fibrillary acidic protein by DNA methylation in human malignant gliomas Neuro Oncol. 13 2011 42 50
201. D. Rial, D.R. Lara, and R.A. Cunha The adenosine neuromodulation system in schizophrenia Int. Rev. Neurobiol. 119 2014 395 449
202. J.A. Ribeiro What can adenosine neuromodulation do for neuroprotection? Curr. Drug Targets CNS Neurol. Disord. 4 2005 325 329
203. J.A. Ribeiro, and A.M. Sebastiao Modulation and metamodulation of synapses by adenosine Acta Physiol. (Oxf.) 199 2010 161 169
204. F. Rizzo, G. Riboldi, S. Salani, M. Nizzardo, C. Simone, S. Corti, and E. Hedlund Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis Cell. Mol. Life Sci. 71 2014 999 1015
205. W. Robberecht, and T. Philips The changing scene of amyotrophic lateral sclerosis Nat. Rev. Neurosci. 14 2013 248 264
206. D.L. Rosin, B.D. Hettinger, A. Lee, and J. Linden Anatomy of adenosine A2A receptors in brain: morphological substrates for integration of striatal function Neurology 61 2003 S12 S18
207. R. Rusina, P. Ridzon, P. Kulist'ak, O. Keller, A. Bartos, M. Buncova, L. Fialova, F. Koukolik, and R. Matej Relationship between ALS and the degree of cognitive impairment, markers of neurodegeneration and predictors for poor outcome. A prospective study Eur. J. Neurol. 17 2010 23 30
208. A.B. Salmina Neuron-glia interactions as therapeutic targets in neurodegeneration J. Alzheimers Dis. 16 2009 485 502
209. J.V. Sanchez-Mut, E. Aso, H. Heyn, T. Matsuda, C. Bock, I. Ferrer, and M. Esteller Promoter hypermethylation of the phosphatase DUSP22 mediates PKA-dependent TAU phosphorylation and CREB activation in Alzheimer's disease Hippocampus 24 2014 363 368
210. S. Satoh, H. Matsumura, and O. Hayaishi Involvement of adenosine A2A receptor in sleep promotion Eur. J. Pharmacol. 351 1998 155 162
211. S. Satoh, H. Matsumura, N. Koike, Y. Tokunaga, T. Maeda, and O. Hayaishi Region-dependent difference in the sleep-promoting potency of an adenosine A2A receptor agonist Eur. J. Neurosci. 11 1999 1587 1597
212. T.E. Scammell, D.Y. Gerashchenko, T. Mochizuki, M.T. McCarthy, I.V. Estabrooke, C.A. Sears, C.B. Saper, Y. Urade, and O. Hayaishi An adenosine A2a agonist increases sleep and induces Fos in ventrolateral preoptic neurons Neuroscience 107 2001 653 663
213. N. Scarmeas, L.S. Honig, H. Choi, J. Cantero, J. Brandt, D. Blacker, M. Albert, J.C. Amatniek, K. Marder, K. Bell, W.A. Hauser, and Y. Stern Seizures in Alzheimer disease: who, when, and how common? Arch. Neurol. 66 2009 992 997
214. S.N. Schiffmann, G. Fisone, R. Moresco, R.A. Cunha, and S. Ferre Adenosine A(2A) receptors and basal ganglia physiology Prog. Neurobiol. 83 2007 277 292
215. C. Schmidt, M. Wolff, M. Weitz, T. Bartlau, C. Korth, and I. Zerr Rapidly progressive Alzheimer disease Arch. Neurol. 68 2011 1124 1130
216. P. Seeman, and S. Kapur Schizophrenia: more dopamine, more D2 receptors Proc. Natl. Acad. Sci. U. S. A. 97 2000 7673 7675
217. G. Seifert, G. Carmignoto, and C. Steinhauser Astrocyte dysfunction in epilepsy Brain Res. Rev. 63 2010 212 221
218. G. Seifert, K. Schilling, and C. Steinhauser Astrocyte dysfunction in neurological disorders: a molecular perspective Nat. Rev. Neurosci. 7 2006 194 206
219. G. Seifert, and C. Steinhauser Neuron-astrocyte signaling and epilepsy Exp. Neurol. 244 2013 4 10
220. H.-Y. Shen, J.E. Coelho, N. Ohtsuka, P.M. Canas, Y.-J. Day, Q.-Y. Huang, N. Rebola, L. Yu, D. Boison, R.A. Cunha, J. Linden, J.Z. Tsien, and J.F. Chen A critical role of the adenosine A2A receptor in extra-striatal neurons in modulating psychomotor activity as revealed by opposite phenotypes of striatum- and forebrain-A2A receptor knockouts J. Neurosci. 28 2008 2970 2975
221. H.-Y. Shen, H. Sun, M.M. Hanthorn, Z. Zhi, J.-Q. Lan, D.J. Poulsen, R. Wang, and D. Boison Overexpression of adenosine kinase in cortical astrocytes generates focal neocortical epilepsy in mice J. Neurosurg. 120 2014 628 638
222. H.Y. Shen, T.A. Lusardi, R.L. Williams-Karnesky, J.Q. Lan, D.J. Poulsen, and D. Boison Adenosine kinase determines the degree of brain injury after ischemic stroke in mice J. Cereb. Blood Flow Metab. 31 2011 1648 1659 PMCID: PMC3137468
223. H.Y. Shen, P. Singer, N. Lytle, C.J. Wei, J.Q. Lan, R.L. Williams-Karnesky, J.F. Chen, B.K. Yee, and D. Boison Adenosine augmentation ameliorates psychotic and cognitive endophenotypes of schizophrenia J. Clin. Investig. 122 2012 2567 2577
224. C.G. Silva, L.O. Porciuncula, P.M. Canas, C.R. Oliveira, and R.A. Cunha Blockade of adenosine A(2A) receptors prevents staurosporine-induced apoptosis of rat hippocampal neurons Neurobiol. Dis. 27 2007 182 189
225. J.E. Simpson, P.G. Ince, G. Lace, G. Forster, P.J. Shaw, F. Matthews, G. Savva, C. Brayne, S.B. Wharton, M.R.C.C. Function Ageing Neuropathology Study, G Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain Neurobiol. Aging 31 2010 578 590
226. M.V. Sofroniew, and H.V. Vinters Astrocytes: biology and pathology Acta Neuropathol. 119 2010 7 35
227. W. Song, A. Patel, H.Y. Qureshi, D. Han, H.M. Schipper, and H.K. Paudel The Parkinson disease-associated A30P mutation stabilizes alpha-synuclein against proteasomal degradation triggered by heme oxygenase-1 over-expression in human neuroblastoma cells J. Neurochem. 110 2009 719 733
228. P.S. Spencer, R.C. Fry, V.S. Palmer, and G.E. Kisby Western Pacific ALS-PDC: a prototypical neurodegenerative disorder linked to DNA damage and aberrant proteogenesis? Front. Neurol. 3 2012 180
229. P.S. Spencer, M.R. Lasarev, V.S. Palmer, and G.E. Kisby Neurotoxic cycad components and Western Pacific ALS/PDC Ann. Neurol. 68 2010 975 976 author reply 976
230. M. Sta, R.M. Sylva-Steenland, M. Casula, J.M. de Jong, D. Troost, E. Aronica, and F. Baas Innate and adaptive immunity in amyotrophic lateral sclerosis: evidence of complement activation Neurobiol. Dis. 42 2011 211 220
231. D.B. Stanimirovic, and A. Friedman Pathophysiology of the neurovascular unit: disease cause or consequence? J. Cereb. Blood Flow Metab. 32 2012 1207 1221
232. M.L. Steele, and S.R. Robinson Reactive astrocytes give neurons less support: implications for Alzheimer's disease Neurobiol. Aging 33 2012 423 e421-413
233. + channels and gap junction coupling Glia 60 2012 1192 1202
234. T.W. Stone, S. Ceruti, and M.P. Abbracchio Adenosine receptors and neurological disease: neuroprotection and neurodegeneration Handb. Exp. Pharmacol. 193 2009 535 587
235. F.E. Studer, D.E. Fedele, A. Marowsky, C. Schwerdel, K. Wernli, K. Vogt, J.M. Fritschy, and D. Boison Shift of adenosine kinase expression from neurons to astrocytes during postnatal development suggests dual functionality of the enzyme Neuroscience 142 2006 125 137
236. J. Suvisaari, and O. Mantere Inflammation theories in psychotic disorders: a critical review Infect. Disord. Drug Targets 13 2013 59 70
237. J.W. Swann, and J.M. Rho How is homeostatic plasticity important in epilepsy? Adv. Exp. Med. Biol. 813 2014 123 131
238. P. Szot Common factors among Alzheimer's disease, Parkinson's disease, and epilepsy: possible role of the noradrenergic nervous system Epilepsia 53 Suppl. 1 2012 61 66
239. C. Szybala, E.M. Pritchard, A. Wilz, D.L. Kaplan, and D. Boison Antiepileptic effects of silk-polymer based adenosine release in kindled rats Exp. Neurol. 219 2009 126 135
240. M.T. Tebano, A. Martire, R.L. Potenza, C. Gro, R. Pepponi, M. Armida, M.R. Domenici, M.A. Schwarzschild, J.F. Chen, and P. Popoli Adenosine A(2A) receptors are required for normal BDNF levels and BDNF-induced potentiation of synaptic transmission in the mouse hippocampus J. Neurochem. 104 2008 279 286
241. P. Theofilas, S. Brar, K.-A. Stewart, H.-Y. Shen, U.S. Sandau, D.J. Poulsen, and D. Boison Adenosine kinase as a target for therapeutic antisense strategies in epilepsy Epilepsia 52 2011 589 601 PMCID: PMC3075862
242. M. Thom Review: hippocampal sclerosis in epilepsy: a neuropathology review Neuropathol. Appl. Neurobiol. 40 2014 520 543
243. M. Thom, S. Eriksson, L. Martinian, L.O. Caboclo, A.W. McEvoy, J.S. Duncan, and S.M. Sisodiya Temporal lobe sclerosis associated with hippocampal sclerosis in temporal lobe epilepsy: neuropathological features J. Neuropathol. Exp. Neurol. 68 2009 928 938
244. P. Tibrewal, and R. Dhillon Caffeine induced psychotic exacerbation Aust. N. Z. J. Psychiatry 45 2011 179 180
245. S.R. Ticho, and M. Radulovacki Role of adenosine in sleep and temperature regulation in the preoptic area of rats Pharmacol. Biochem. Behav. 40 1991 33 40
246. H. Tost, T. Alam, and A. Meyer-Lindenberg Dopamine and psychosis: theory, pathomechanisms and intermediate phenotypes Neurosci. Biobehav. Rev. 34 2010 689 700
247. A. Tozzi, A. Tscherter, V. Belcastro, M. Tantucci, C. Costa, B. Picconi, D. Centonze, P. Calabresi, and F. Borsini Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission Neuropharmacology 53 2007 783 789
248. L. Tremolizzo, P. Messina, E. Conti, G. Sala, M. Cecchi, L. Airoldi, R. Pastorelli, E. Pupillo, M. Bandettini Di Poggio, M. Filosto, C. Lunetta, C. Agliardi, F. Guerini, J. Mandrioli, A. Calvo, E. Beghi, C. Ferrarese, and E. Consortium Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset Amyotroph. Lateral Scler. Front. Degener. 15 2014 98 105
249. P. Trifilieff, M.L. Rives, E. Urizar, R.A. Piskorowski, H.D. Vishwasrao, J. Castrillon, C. Schmauss, M. Slattman, M. Gullberg, and J.A. Javitch Detection of antigen interactions ex vivo by proximity ligation assay: endogenous dopamine D2-adenosine A2A receptor complexes in the striatum Biotechniques 51 2011 111 118
250. Y. Urade, N. Eguchi, W.M. Qu, M. Sakata, Z.L. Huang, J.F. Chen, M.A. Schwarzschild, J.S. Fink, and O. Hayaishi Sleep regulation in adenosine A2A receptor-deficient mice Neurology 61 2003 S94 S96
251. D. van Calker, and K. Biber The role of glial adenosine receptors in neural resilience and the neurobiology of mood disorders Neurochem. Res. 30 2005 1205 1217
252. I. Van der Auwera, S. Wera, F. Van Leuven, and S.T. Henderson A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease Nutr. Metab. (Lond.) 2 2005 28
253. A. Van Dycke, R. Raedt, I. Dauwe, T. Sante, T. Wyckhuys, A. Meurs, K. Vonck, W. Wadman, and P. Boon Continuous local intrahippocampal delivery of adenosine reduces seizure frequency in rats with spontaneous seizures Epilepsia 51 2010 1721 1728
254. A. Vezzani, E. Aronica, A. Mazarati, and Q.J. Pittman Epilepsy and brain inflammation Exp. Neurol. 244 2013 11 21
255. A. Vezzani, T. Ravizza, S. Balosso, and E. Aronica Glia as a source of cytokines: implications for neuronal excitability and survival Epilepsia 49 Suppl. 2 2008 24 32
256. M. Vila, V. Jackson-Lewis, C. Guegan, D.C. Wu, P. Teismann, D.K. Choi, K. Tieu, and S. Przedborski The role of glial cells in Parkinson's disease Curr. Opin. Neurol. 14 2001 483 489
257. R.M. Virus, S. Ticho, M. Pilditch, and M. Radulovacki A comparison of the effects of caffeine, 8-cyclopentyltheophylline, and alloxazine on sleep in rats. Possible roles of central nervous system adenosine receptors Neuropsychopharmacology 3 1990 243 249
258. C.J. Wei, E. Augusto, C.A. Gomes, P. Singer, Y. Wang, D. Boison, R.A. Cunha, B.K. Yee, and J.F. Chen Regulation of fear responses by striatal and extrastriatal adenosine a receptors in forebrain Biol. Psychiatry 75 2014 855 863
259. R.L. Williams-Karnesky, U.S. Sandau, T.A. Lusardi, N.K. Lytle, J.M. Farrell, E.M. Pritchard, D.L. Kaplan, and D. Boison Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis J. Clin. Investig. 123 2013 3552 3563
260. J.M. Williams, and K.K. Gandhi Use of caffeine and nicotine in people with schizophrenia Curr. Drug Abuse Rev. 1 2008 155 161
261. A. Wilz, E.M. Pritchard, T. Li, J.Q. Lan, D.L. Kaplan, and D. Boison Silk polymer-based adenosine release: therapeutic potential for epilepsy Biomaterials 29 2008 3609 3616
262. S.C. Woolley, Y. Zhang, N. Schuff, M.W. Weiner, and J.S. Katz Neuroanatomical correlates of apathy in ALS using 4 Tesla diffusion tensor MRI Amyotroph. Lateral Scler. 12 2011 52 58
263. T. Wyss-Coray, J.D. Loike, T.C. Brionne, E. Lu, R. Anankov, F. Yan, S.C. Silverstein, and J. Husemann Adult mouse astrocytes degrade amyloid-beta in vitro and in situ Nat. Med. 9 2003 453 457
264. D. Xiao, E. Bastia, Y.H. Xu, C.L. Benn, J.H. Cha, T.S. Peterson, J.F. Chen, and M.A. Schwarzschild Forebrain adenosine A2A receptors contribute to L-3,4-dihydroxyphenylalanine-induced dyskinesia in hemiparkinsonian mice J. Neurosci. 26 2006 13548 13555
265. B.K. Yee, P. Singer, J.F. Chen, J. Feldon, and D. Boison Transgenic overexpression of adenosine kinase in brain leads to multiple learning impairments and altered sensitivity to psychomimetic drugs Eur. J. Neurosci. 26 2007 3237 3252
266. L. Yu, H.Y. Shen, J.E. Coelho, I.M. Araujo, Q.Y. Huang, Y.J. Day, N. Rebola, P.M. Canas, E.K. Rapp, J. Ferrara, D. Taylor, C.E. Muller, J. Linden, R.A. Cunha, and J.F. Chen Adenosine A2A receptor antagonists exert motor and neuroprotective effects by distinct cellular mechanisms Ann. Neurol. 63 2008 338 346
267. Z. Zhao, D.J. Lange, A. Voustianiouk, D. MacGrogan, L. Ho, J. Suh, N. Humala, M. Thiyagarajan, J. Wang, and G.M. Pasinetti A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis BMC Neurosci. 7 2006 29
268. F.W. Zhou, and S.N. Roper Impaired hippocampal memory function and synaptic plasticity in experimental cortical dysplasia Epilepsia 53 2012 850 859
269. Q. Zhu, L. Wang, Y. Zhang, F.H. Zhao, J. Luo, Z. Xiao, G.J. Chen, and X.F. Wang Increased expression of DNA methyltransferase 1 and 3a in human temporal lobe epilepsy J. Mol. Neurosci. 46 2012 420 426
270. R. Zorec, A. Araque, G. Carmignoto, P.G. Haydon, A. Verkhratsky, and V. Parpura Astroglial excitability and gliotransmission: an appraisal of Ca2+ as a signalling route ASN Neuro 4 2012